← Back to Search

Transcranial direct electrical stimulation (tDCS) for Neuropathic Pain

N/A
Waitlist Available
Led By Eva Widerstrom-Noga, Phd
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to two weeks
Awards & highlights

Study Summary

This trial will test whether a combination of two procedures, BI and tDCS, can help reduce neuropathic pain.

Eligible Conditions
  • Neuropathic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Neuropathic Pain Severity
Change in Performance of Body Part Processing
Secondary outcome measures
Change in Sensory Thresholds

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BI-TDCS Stimulation GroupExperimental Treatment2 Interventions
Participants in this group will receive the BI and TDCS interventions for 10 sessions over two weeks.
Group II: BI-TDCS (Sham) Stimulation GroupPlacebo Group2 Interventions
Participants in this group will receive the BI and TDCS (Sham) interventions for 10 sessions over two weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct electrical stimulation (tDCS)
2021
N/A
~10

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
899 Previous Clinical Trials
409,674 Total Patients Enrolled
3 Trials studying Neuropathic Pain
69 Patients Enrolled for Neuropathic Pain
FloridaOTHER
9 Previous Clinical Trials
1,076 Total Patients Enrolled
Eva Widerstrom-Noga, PhdPrincipal Investigator - University of Miami
University of Miami

Media Library

Bodily Illusions (BI) Procedure Clinical Trial Eligibility Overview. Trial Name: NCT04578574 — N/A
Neuropathic Pain Research Study Groups: BI-TDCS Stimulation Group, BI-TDCS (Sham) Stimulation Group
Neuropathic Pain Clinical Trial 2023: Bodily Illusions (BI) Procedure Highlights & Side Effects. Trial Name: NCT04578574 — N/A
Bodily Illusions (BI) Procedure 2023 Treatment Timeline for Medical Study. Trial Name: NCT04578574 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical trial accept participants aged forty and above?

"This trial is open to those aged 18 or above, and below the age of 75."

Answered by AI

Are there any eligibility criteria for participation in this clinical experiment?

"To be included in the trial, participants must satisfy two criteria: they should have neuralgia and be between 18 to 75 years old. The total number of enrollees stands at 16 individuals."

Answered by AI

Is recruitment for this medical study still available?

"Affirmative. According to information on clinicaltrials.gov, this research is actively searching for 16 patients from a single site since its posting date of January 13th 2021 and most recent edit of October 20th 2022."

Answered by AI

How many individuals are eligible to partake in this research?

"Affirmative. Clinicaltrials.gov has information that shows this medical trial is currently enrolling participants, after first being published on January 13th 2021 and most recently updated on October 20th 2022. Sixteen study subjects are needed from a single site."

Answered by AI

Who else is applying?

What state do they live in?
Utah
What site did they apply to?
University of Miami
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain
Eva Widerstrom-Noga 2021. "Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04578574.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top